Pre-operative IRX-2 in Early Stage Breast Cancer (ESBC)

Clinical trial NCT02950259 · COMPLETED

Trial details

NCT number: NCT02950259
Sponsor: Providence Health & Services
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Breast Neoplasm Breast Neoplasm, Male Triple Negative Breast Cancer

Start date: 2017-02-09
Primary completion: 2019-05-13
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.